ReviewDirect · Growth
Quant Large & Mid Cap Fund
quant Mutual FundEquity Scheme - Large & Mid Cap Fund13.7 years
The scheme seeks to provide capital appreciation by investing in a portfolio of Large and Midcap companies.
- NAV
- 134.7755
- 15 Sept 2026
- 1Y
- +8.4%
- Trailing CAGR
- AUM
- ₹3,496.35 Cr
- 31 Aug 2026
- Volatility
- n/a
- History still thin
NAV
Path not in current snapshots
n/a
Returns
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
- 1Y+8.4%
- 3Y+13.6%
- 5Y+15.4%
- 10Y+15.7%
- SI+17.7%
SIP XIRR
Equal monthly instalments to latest NAV
- 1Y+12.3%
- 3Y+7.0%
- 5Y+13.4%
- 10Y+17.1%
- Since inception
- +17.7%
- Calendar-day CAGR
- Excess 1Y
- +5.1%
- Category median, same plan and option
- 3Y win rate
- +81%
- Windows beating the median
- 3Y percentile
- 59
- Vs comparable share classes
- Worst rolling 3Y
- -6.9%
- 2635 daily-ending windows
- Median rolling 3Y
- +20.9%
- Calendar-day CAGR
- Positive rolling 5Y
- +100%
- 2142 daily-ending windows
- SIP 3Y XIRR
- +7.0%
- Simulated monthly SIP
Drawdown
Peak to trough from a running NAV high. Move across the path to read a date.
Drawdown
Path not in current snapshots
n/a
- Average recovery
- 28 days
- 99 recovered episodes
- Longest recovery
- 1723 days
- Trough to prior peak
- Current spell
- 718 days
- Days below latest peak
- Time below peak
- +92%
- NAV observations
27 May 2015 – 17 Nov 2020
Trough 29 Feb 2016 · recovered in 1723 days
-45.7%
27 Sept 2024 – open
Trough 4 Mar 2025 · not recovered
-24.1%
9 Jan 2013 – 28 Mar 2014
Trough 28 Aug 2013 · recovered in 212 days
-21.3%
11 Apr 2022 – 7 Sept 2022
Trough 20 Jun 2022 · recovered in 79 days
-17.5%
Dimensions
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
59
Vs category
82
Consistency
69
Risk-adjusted
n/a
Drawdown
0
Mean
53
Portfolio
31 Aug 2026 · 38 holdings · top 10 are 77.4%.
- Top 5
- 49.8%
- Top 10
- 77.4%
- Largest holding
- 21.3%
- Effective holdings
- 10.3
Repo
Unspecified
21.3%
Aurobindo Pharma Ltd
Healthcare
9.7%
Lloyds Metals and Energy Ltd
Materials
9.0%
Samvardhana Motherson International Ltd
Consumer Discretionary
8.1%
Adani Enterprises Ltd
Materials
6.4%
Decision
Quantitative read of the live evidence. An explanation can only restate what is already here.
As of 15 Sept 2026
Review
Engine status
Review
Closer look
Why this status
- Maximum drawdown exceeded 35%.
Supporting reads
- The fund beat the category median in 81% of rolling 3-year windows.
Risk metrics are withheld because the NAV history contains an implausible daily move above 50%.
Worth investigating
Same-category peers with enough history to inspect beside this fund.
Motilal Oswal Large and Midcap Fund
Motilal Oswal Mutual Fund
- 1Y
- +7.2%
- 3Y
- +21.2%
- Vol
- 19.4%
- Max DD
- -37.4%
- Sharpe
- 0.87
- 3Y win
- +98%
- Shallower drawdown
- Higher win rate vs category
- Higher trailing returns
Baroda BNP Paribas Large and Mid Cap fund
Baroda BNP Paribas Mutual Fund
- 1Y
- +1.4%
- 3Y
- +12.5%
- Vol
- 14.9%
- Max DD
- -20.6%
- Sharpe
- 0.94
- 3Y win
- +81%
- Shallower drawdown
- Higher win rate vs category
Caveat: Lower trailing returns
Edelweiss Large & Mid Cap Fund
Edelweiss Mutual Fund
- 1Y
- +2.5%
- 3Y
- +13.2%
- Vol
- 15.7%
- Max DD
- -34.9%
- Sharpe
- 0.74
- 3Y win
- +88%
- Shallower drawdown
- Higher win rate vs category
Caveat: Lower trailing returns
Bandhan Large & Mid Cap Fund
Bandhan Mutual Fund
- 1Y
- +4.7%
- 3Y
- +17.3%
- Vol
- 15.8%
- Max DD
- -38.5%
- Sharpe
- 0.68
- 3Y win
- +61%
- Shallower drawdown
- Higher trailing returns
ICICI Prudential Large & Mid Cap Fund
ICICI Prudential Mutual Fund
- 1Y
- +2.2%
- 3Y
- +14.9%
- Vol
- 15.3%
- Max DD
- -37.4%
- Sharpe
- 0.72
- 3Y win
- +51%
- Shallower drawdown
- Higher trailing returns